Navigation Links
New FT-IR Spectrometer Series from Varian, Inc.

Unrivalled Performance Meets Simplicity for Routine and Research


PALO ALTO, Calif., March 31 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new 600-IR series of FT-IR (Fourier Transform Infrared) spectrometers, microscopes and imaging solutions. The series comprises a range of products for both routine analyses and advanced research applications.

FT-IR spectroscopy provides a simple, fast analytical tool to identify or characterize samples in a wide range of applications from QA/QC testing of raw materials in pharmaceutical laboratories to the detection of trace amounts of explosives or narcotics in forensic analysis.

FT-IR spectroscopy also has the ability to reveal the chemical fingerprint of a material, even in mixtures, allowing multiple materials to be identified simultaneously. Commonly used with a wide range of accessories such as ATR (Attenuated Total Reflectance), microscopes and imaging, FT-IR has pioneered new applications in areas such as biotechnology, food and agriculture and homeland security.

The Varian 600-IR series of spectrometers deliver the highest energy throughput, making them the ideal solution for research or method development applications. Designed for unrivalled performance, this new range of spectrometers and microscopes enables users to run samples faster, while maintaining the highest accuracy and reproducibility, saving both time and money.

Combining power with simplicity, the Varian 600-IR series intuitive, easy- to-use software and "plug and play" hardware simplify analyses and maximize output for both novice and expert users. The ability for users to upgrade their new instrumentation ensures that they can purchase a system that fits their budget today and will meet their needs in the future.

"The 600-IR Series offers unrivalled performance under real world conditions," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "The combination of superior performance and reduced complexity offers information rich detection to users in a broad range of applications."

For more technical information about Varian's FT-IR instrumentation, please visit

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site:

For More Information, Contact:

Public Relations

Varian, Inc.


SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
2. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
3. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
4. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
5. U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series
6. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
7. New nanotechnology television series does sweat the small stuff
8. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
9. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
10. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
11. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Post Your Comments:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):